SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-20-008596
Filing Date
2020-08-06
Accepted
2020-08-06 16:18:22
Documents
67
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT cdxc_10q.htm   iXBRL 10-Q 1282478
2 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER cdxc_ex311.htm EX-31.1 5754
3 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER cdxc_ex312.htm EX-31.2 5734
4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 cdxc_ex321.htm EX-32.1 3794
  Complete submission text file 0001654954-20-008596.txt   5489257

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cdxc-20200630.xsd EX-101.SCH 38738
6 XBRL CALCULATION FILE cdxc-20200630_cal.xml EX-101.CAL 47220
7 XBRL DEFINITION FILE cdxc-20200630_def.xml EX-101.DEF 110696
8 XBRL LABEL FILE cdxc-20200630_lab.xml EX-101.LAB 249364
9 XBRL PRESENTATION FILE cdxc-20200630_pre.xml EX-101.PRE 223839
10 EXTRACTED XBRL INSTANCE DOCUMENT cdxc_10q_htm.xml XML 1256477
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
ChromaDex Corp. (Filer) CIK: 0001386570 (see all company filings)

IRS No.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37752 | Film No.: 201081930
SIC: 2833 Medicinal Chemicals & Botanical Products
Office of Life Sciences